Related references
Note: Only part of the references are listed.Proximal tubular dysfunction in pregnant women receiving tenofovir disoproxil fumarate to prevent mother-to-child transmission of hepatitis B virus
Geoffroy Liegeon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)
Long-term safety of infants from mothers with chronic hepatitis B treated with tenofovir disoproxil in China
Calvin Q. Pan et al.
GUT (2022)
Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection
Tahrima Kayes et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)
Growth and Neurodevelopment Outcomes in HIV-, Tenofovir-, and Efavirenz-Exposed Breastfed Infants in the PMTCT Option B plus Program in Malawi
Atupele P. Kapito-Tembo et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2021)
Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis
Anna L. Funk et al.
LANCET INFECTIOUS DISEASES (2021)
Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective, Observational Study
Qing-Lei Zeng et al.
CLINICAL INFECTIOUS DISEASES (2021)
Plasma and Breast Milk Pharmacokinetics of Tenofovir Disoproxil Fumarate in Nursing Mother with Chronic Hepatitis B-Infant Pairs
U. S. Erturk et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load
Baijun Li et al.
HEPATOLOGY INTERNATIONAL (2021)
Chronic hepatitis B in pregnant women: Current trends and approaches
Maria Belopolskaya et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate
Wan-Hsin Wen et al.
JOURNAL OF HEPATOLOGY (2020)
Rapid quantification of tenofovir in umbilical cord plasma and amniotic fluid in hepatitis B mono-infected pregnant women during labor by ultra-performance liquid chromatography/tandem mass spectrometry
Zhiyuan Ma et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2020)
Hepatitis B-management of acute infection and active inflammation in pregnancy-a hepatologist's perspective
Grace Lai-Hung Wong et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2020)
The safety of antiviral therapy and drug withdrawal for the prevention of mother-to-child transmission of HBV during pregnancy
Li-Xin Xiao et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Guides concerning tenofovir exposure via breastfeeding: A comparison of drug dosages by developmental stage
Xiaotong Hu et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
Transporters in the Mammary Gland-Contribution to Presence of Nutrients and Drugs into Milk
Alba M. Garcia-Lino et al.
NUTRIENTS (2019)
Management Algorithm for Interrupting Mother-to-Child Transmission of Hepatitis B Virus
Jinlin Hou et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Taiwan consensus statement on the management of chronic hepatitis B
Rong-Nan Chien et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2019)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Chronic Hepatitis B Infection A Review
Lydia S. Y. Tang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother-infant pairs
Catriona Waitt et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Tenofovir Versus Placebo to Prevent Perinatal Transmission of Hepatitis B
[Anonymous]
OBSTETRICAL & GYNECOLOGICAL SURVEY (2018)
Efficacy of tenofovir in preventing perinatal transmission of HBV infection in pregnant women with high viral loads
Yayun Lin et al.
SCIENTIFIC REPORTS (2018)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Pharmacokinetics and Placental Transfer of Elvitegravir, Dolutegravir, and Other Antiretrovirals during Pregnancy
Bassam H. Rimawi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Multiple SLC and ABC Transporters Contribute to the Placental Transfer of Entecavir
Zhiyuan Ma et al.
DRUG METABOLISM AND DISPOSITION (2017)
Human organic anion transporter 2 is an entecavir, but not tenofovir, transporter
Tomomi Furihata et al.
DRUG METABOLISM AND PHARMACOKINETICS (2017)
Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the Option B-Plus approach in Malawi
Leonardo Palombi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load
Calvin Q. Pan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Breastfeeding While Taking Lamivudine or Tenofovir Disoproxil Fumarate: A Review of the Evidence
Stephan Ehrhardt et al.
CLINICAL INFECTIOUS DISEASES (2015)
Concentrations of Tenofovir and Emtricitabine in Breast Milk of HIV-1-Infected Women in Abidjan, Cote d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2
Sihem Benaboud et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their Infants
Patricia M. Flynn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2)
Yuichi Uwai et al.
PHARMACEUTICAL RESEARCH (2007)
The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk
JW Jonker et al.
NATURE MEDICINE (2005)
Transporter gene expression in lactating and nonlactating human mammary epithelial cells using real-time reverse transcription-polymerase chain reaction
J Alcorn et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Share Paper
